U.S. Paper and Forestry Products Stock News

NYSE:VYX
NYSE:VYXSoftware

NCR Voyix (VYX) Stock Looks Fully Priced After Years Of Weak Returns

NCR Voyix stock has fallen sharply over the past several years, yet the current market multiples still suggest the shares may be pricing in a lot of optimism. With a mixed valuation score and a long period of weak returns, investors are left weighing whether the current price offers enough compensation for the risks. NCR Voyix has delivered a decline of 65.5% over the past 5 years, which points to a long stretch where shareholders have not been rewarded. Future cash generation from NCR...
NYSE:UAMY
NYSE:UAMYMetals and Mining

Will UAMY’s Shift To Self-Mined Antimony Ore Redefine Its Cost Structure And Supply Resilience?

Earlier this year, United States Antimony Corporation reported a company-wide update on its mining activities in Alaska, Montana, and Canada, confirming progress on multiple claims such as Ester Dome, Stibnite Creek, and Nolan Creek and outlining plans to begin mining operations later in 2026. The company also indicated that 2026 will be the first year it uses antimony ore from its own mines to fulfill customer contracts, a shift that could reshape its cost structure and supply reliability...
NYSE:KNX
NYSE:KNXTransportation

Knight Swift Transportation Holdings (KNX) Could Be 17% Undervalued After Q2 Earnings

Why Knight-Swift Transportation Holdings Stock Is Back in Focus After Q2 Earnings Knight-Swift Transportation Holdings (KNX) moved back onto investor watchlists after reporting second quarter 2026 results on 22 July, with sales, revenue and net income all higher than the same period in 2025. See our latest analysis for Knight-Swift Transportation Holdings. The Q2 earnings release has come after a strong run in Knight-Swift Transportation Holdings shares, with a 37.12% year to date share price...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics (DGX) Lifts 2026 Outlook As Investors Ask If The Stock Is Fully Valued

Quest Diagnostics (DGX) stock has been in focus after the company reported second quarter and six month 2026 results and raised its full year revenue and earnings guidance, indicating that the company now expects higher financial performance. See our latest analysis for Quest Diagnostics. Quest Diagnostics shares have picked up pace over 2026, with a 1‑month share price return of 8.34%, a 90‑day gain of 23.58%, and a 1‑year total shareholder return of 37.26%. This reflects recent share price...
NYSE:KOS
NYSE:KOSOil and Gas

Kosmos Energy (KOS) Stock Still Looks Cheap Even After Big Gains

Kosmos Energy stock has surged year to date, yet its valuation checks still flag the shares as leaning cheap on several measures. For investors, that mix of strong price momentum and an apparently supportive valuation is likely to be the key focus right now. Year to date, Kosmos Energy has returned 171.1%, which puts the recent share price strength front and center for anyone assessing what happens next. Future cash generation from existing assets can support the current share price...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros (BROS) Heads Into Q2 Earnings With Expansion In Focus On Valuation

Why Dutch Bros stock is in focus ahead of Q2 earnings Investor attention on Dutch Bros (BROS) is building ahead of its Q2 2026 earnings release on August 5. Analysts expect year-over-year growth in both revenue and earnings. At the same time, Dutch Bros continues to add new shops in markets like South Carolina, Georgia, Illinois, and North Carolina. This keeps expansion and unit economics at the center of the story for anyone following the stock. See our latest analysis for Dutch Bros. Dutch...
NYSE:PNC
NYSE:PNCBanks

Is PNC’s US$2 Billion Branch and Cybersecurity Push Reframing the Investment Case for PNC (PNC)?

PNC Bank recently opened its 50th new branch in Hialeah, Florida, marking a key milestone in its coast-to-coast build-out of more than 300 locations and an approximately US$2.00 billion program to expand and renovate its U.S. branch network by 2030. This branch rollout, alongside the appointment of Christian Winward as chief information security officer, highlights PNC’s continued emphasis on both physical presence and cybersecurity as it scales its national franchise. Now, we’ll explore how...
NYSE:AUB
NYSE:AUBBanks

How Investors Are Reacting To Atlantic Union Bankshares (AUB) New Subordinated Debt And Ongoing Dividends

Atlantic Union Bankshares recently completed a US$250,000,000 fixed-to-floating rate subordinated notes offering due 2036 and, in July 2026, declared quarterly dividends on both its common stock and 6.875% Series A preferred shares. Together, the new junior unsecured notes and continued dividend payments highlight the company’s current focus on funding flexibility while maintaining ongoing cash returns to shareholders. We’ll now examine how the new US$250,000,000 subordinated debt issuance...
NYSE:GE
NYSE:GEAerospace & Defense

The Bull Case For General Electric (GE) Could Change Following Surging Aerospace Engine Services Revenue Growth

In recent days, GE Aerospace reported that its Commercial Engines & Services segment delivered a 27% revenue increase in Q2 2026, supported by strong services, spare parts demand, LEAP engine deliveries, and a series of significant engine and long-term service agreements with major airlines. At the same time, management highlighted persistent cost and margin pressures, meaning investors are weighing robust top-line and cash generation against a more gradual profitability improvement path...
NYSE:DELL
NYSE:DELLTech

Is Dell Technologies (DELL) Fairly Valued After Its AI Infrastructure Wins?

Dell Technologies (DELL) has moved into the spotlight after a run of AI focused infrastructure deals, including the Volta AI factory contract, Texas A&M’s IGNITE platform and an expanded distribution agreement with D&H Distributing. See our latest analysis for Dell Technologies. The recent AI infrastructure announcements come on top of a powerful run in Dell Technologies stock, with a 90 day share price return of 95.67% and year to date share price return of 265.63%, while the 1 year total...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

Power Integrations (POWI) Extends PowiGaN To 2200 V, Is The Stock Fully Priced?

Why Power Integrations Stock Is Back in Focus After Its PowiGaN Update Power Integrations (POWI) just announced that its PowiGaN gallium nitride technology now supports up to 2,200 V, positioning the company for high-voltage data centers, electric vehicles, renewables and HVDC infrastructure. This rating sits above other commercially available GaN offerings described in the announcement. For you as an investor, the key question is how this expanded voltage range could influence Power...
NYSE:SO
NYSE:SOElectric Utilities

Southern (SO) Earnings And $2.4b Notes Put Fair Value Back In Focus

Southern (SO) has drawn fresh attention after announcing and then completing two Rule 144A convertible step up note offerings totaling about $2.4b, alongside reporting its second quarter 2026 earnings results. See our latest analysis for Southern. Southern’s recent earnings update and the $2.4b in new convertible step up notes arrive as momentum cools slightly in the short term. The company has seen a 30 day share price return decline of 4.83%, yet the 5 year total shareholder return of...
NasdaqCM:EGBN
NasdaqCM:EGBNBanks

Banking Sector Stocks To Watch If Rate Hike Talk Gains Ground

Rising rate talk is back on the table after Minneapolis Fed President Neel Kashkari pushed for an immediate hike, and that has put fresh attention on Banking Sector Stocks. Higher policy rates can lift funding costs and weigh on equity valuations, yet they can also reshape how banks earn from lending and deposits. For investors, one key question is which stocks appear better positioned if this tightening view gains traction. This article walks through 3 stocks from our Banking Sector Stocks...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

How Investors May Respond To Nurix Therapeutics (NRIX) Advancing Bexobrutideg Into Registrational Phase 3 With Roche

Nurix Therapeutics recently reported two key milestones: a US$10 million payment under its Sanofi collaboration tied to a first-in-human STAT6 degrader trial and the first patient enrolled in a global Phase 3 DAYBreak CLL-306 study of bexobrutideg with Roche in relapsed or refractory CLL/SLL. These updates highlight how Nurix’s DEL-AI discovery platform and partnership model can convert early discovery work into late-stage trials and substantial future milestone eligibility, while preserving...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed Martin (LMT) Just Put Sensor Powered AI In Control Of Fighter Intercepts

Lockheed Martin (NYSE:LMT) reported a key AI milestone with Skunk Works running sensor-powered AI autonomy on a fighter aircraft in flight. The system directed 27 real-time air intercepts using operational sensor data rather than lab simulations. The test marks a shift from simulated environments to live, AI-controlled operations in the air. Lockheed Martin sits at the center of US defense and aerospace spending, and this AI advance adds a new layer to its aircraft and mission systems work...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Virgin Galactic (SPCE) Stock Still Looks Cheap Despite Big Risks

Virgin Galactic Holdings stock has had a harsh five year run, with the share price result implying that long term holders have seen almost all of their capital eroded, yet some valuation checks still suggest the stock is not obviously expensive at current levels. Recent short term gains sit against that long decline, which raises questions about how much of the underlying risk profile is now reflected in the price. Over the past five years, Virgin Galactic Holdings has delivered a return of...
NasdaqCM:QUBT
NasdaqCM:QUBTTech

Is QUBT’s New CRO-CPO Duo a Turning Point for Its Commercial and Product Strategy?

On July 17, 2026, Quantum Computing Inc. appointed Susan G. Hunt as Chief Revenue Officer and moved former CRO Dr. Pouya Dianat into the new role of Chief Product Officer to concentrate on product development. This leadership reshuffle pairs an experienced enterprise revenue builder with an internal product specialist, potentially tightening the link between QCi’s commercial execution and its quantum technology roadmap. We’ll now examine how Hunt’s appointment as Chief Revenue Officer may...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Does FILSPARI-Driven Revenue Growth And Wider Losses Change The Bull Case For Travere Therapeutics (TVTX)?

Travere Therapeutics reported past second-quarter 2026 results with revenue rising to US$169.58 million from US$114.45 million a year earlier, while net loss increased to US$34.8 million and basic loss per share widened to US$0.37. The quarter highlighted record demand for FILSPARI in IgA nephropathy and an early FSGS launch, alongside pipeline expansion through the in-licensing of civorebrutinib and progress of the pegtibatinase HARMONY program. Against this backdrop of strong...
OTCPK:FBAK
OTCPK:FBAKBanks

Is First National Bank Alaska (FBAK) Below Fair Value On Earnings And Dividend News?

First National Bank Alaska (FBAK) drew fresh attention after reporting half-year net income of US$41.99 million and affirming a US$4.00 per share cash dividend scheduled for payment in mid September 2026. See our latest analysis for First National Bank Alaska. At a share price of US$324.25, First National Bank Alaska has seen its recent momentum soften a little, with the share price return over the past 90 days down 4.54%. However, the 1 year total shareholder return of 33.94% and 3 year...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

Berkshire Hathaway (BRK.A) Stock Looks Reasonable On Earnings And Cheap Against Fair Value

Berkshire Hathaway stock has climbed 78.2% over the past five years, yet the company still screens as undervalued on both its intrinsic value estimate using the Excess Returns model and on market multiples. With the share price near US$774,300 and fresh headlines about record cash deployment, buybacks and large acquisitions, investors are weighing whether the current level still offers a margin of safety. A 78.2% five year return suggests Berkshire Hathaway has already rewarded long term...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

Is T-Mobile US (TMUS) Cheap After Starlink's Wireless Push Raised Competition Fears?

SpaceX’s Starlink plans to build a terrestrial mobile network have brought competitive pressure into focus for T-Mobile US (TMUS). Investors are reassessing the stock as potential future market share risks gain attention. See our latest analysis for T-Mobile US. Investors have seen momentum in T-Mobile US soften, with the share price delivering a year to date share price return of down 11.21% and a 1 year total shareholder return of down 24.53%, even though the 3 year total shareholder return...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Zscaler (ZS) Wins Gartner Backing, Is The Valuation Upside Still There?

Zscaler (ZS) has been back in focus after Gartner named the company a Leader in both the SASE Platforms and Security Service Edge Magic Quadrants, reinforcing investor attention on its Zero Trust centric stock story. See our latest analysis for Zscaler. At a share price of US$163.22, Zscaler has seen short term momentum return, with a 1 month share price gain of 8.51% and a 7 day gain of 6.15%, while its 1 year total shareholder return has declined 43.59% and the 3 year total shareholder...
NYSE:DG
NYSE:DGConsumer Retailing

Dollar General (DG) Back In Focus As Earnings Beat Meets A Modest Valuation Case

Why Dollar General Stock Is Back In Focus Dollar General (DG) attracted fresh attention after its recent earnings report, where earnings per share came in above estimates. This track record is shaping expectations ahead of the next results on August 27, 2026. See our latest analysis for Dollar General. Dollar General’s recent earnings beats have coincided with a 30 day share price return of 7.69% and a 90 day share price return of 9.36%. However, the year to date share price return is down...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

Copart (CPRT) Could Be 40% Below Fair Value On Strong Q3 Results

Copart (CPRT) reported Q3 2026 results that came in ahead of expectations, yet the stock remains under pressure as investors focus on softer insurance auction volumes and the mixed signals this sends about future demand. See our latest analysis for Copart. At a latest share price of US$29.40, Copart’s stock has been under pressure, with the share price return down 22.16% year to date and the 1 year total shareholder return declining 36.84%. This suggests momentum has been fading despite the...